Associations of characteristics of renal transplant recipients with clinicians' perceptions of adherence to immunosuppressant therapy

Transplantation

Volumn 84, Issue 9, 2007, Pages 1145-1150

  Chisholm, Marie A ^a,b   Kwong, W Jaqueline ^c   Spivey, Christina A ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Graft failure; Medication adherence; Renal transplant

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; DEMOGRAPHY; FEMALE; FOLLOW UP; GRAFT FAILURE; HEALTH INSURANCE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHYSICIAN; PRIORITY JOURNAL; RACE DIFFERENCE; RECIPIENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; TREATMENT OUTCOME; UNITED STATES;

ADULT; CADAVER; EDUCATIONAL STATUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATIENT COMPLIANCE; PHYSICIAN-PATIENT RELATIONS; PHYSICIANS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 36248986290     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000287189.33074.c8     Document Type: Article

References (42)

1. Butler JA, Roderick P, Mullee M, et al. Frequency and impact of non-adherence to immunosuppressants after renal transplantation: A systematic review. Transplantation 2004; 77: 769.
2. Chisholm MA, Mulloy LL, Jagadeesan M, DiPiro JT. Impact of clinical pharmacy services on renal transplant patients' compliance with immunosuppressive medications. Clin Transplant 2001; 15: 330.
3. Frazier P, Davis-Ali S, Dahl K. Correlates of noncompliance among renal transplant recipients. Clin Transplant 1994; 8: 550.
4. Greenstein S, Siegal B. Compliance and noncompliance in patients with functioning renal transplant: A multicenter study. Transplantation 1998; 66: 1718.
5. DeGeest S, Borgermans L, Gemoets H, et al. Incidence, determinants, and consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant recipients. Transplantation 1995; 59: 340.
6. Didlake RH, Dreyfus K, Kerman RH, et al. Patient noncompliance: A major cause of late graft failure in cyclosporine-treated renal transplants. Transplant Proc 1988; 20: 63.
7. Hilbrands LB, Hoitsma AJ, Koene RA. Medication compliance after renal transplantation. Transplantation 1995; 60: 914.
8. Gaston R, Hudson S, War M, et al. Late renal allograft loss: Noncompliance masquerading as chronic rejection. Transplant Proc 1999; 31: 21s-23s.
9. Arias M, Escallada R, de Francisco AL, et al. Return to dialysis after renal transplantation. Which would be the best way? Kidney Int Suppl 2002; 80: 85.
10. Kaló Z. Economic aspects of transplantation. Transplant Proc 2003; 35: 1223.
11. Chisholm MA, Lance CE, Williamson GM, Mulloy LL. Development and validation of the immunosuppressant therapy adherence instrument (ITAS). Patient Educ Couns 2005; 59: 13.
12. Denhaerynck K, Steiger J, Bock A, et al. Prevalence and risk factors of nonadherence with immunosuppressive medication in kidney transplant patients. Am J Transplant 2007; 7: 108.
13. Kiley DJ, Lam CS, Pollak R. A study of treatment compliance following kidney transplantation. Transplantation 1993; 55: 51.
14. Siegal BR, Greenstein SM. Postrenal transplant compliance from the perspective of the African-Americans, Hispanic-Americans, Anglo-Americans. Adv Ren Replace Ther 1997; 4: 46.
15. Schweizer RT, Rovelli M, Pameri D, et al. Noncompliance in organ transplant recipients. Transplantation 1990; 49: 374.
16. Weng FL, Israni AK, Joffe MM, et al. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol 2005; 16: 1839.
17. Vasquez EM, Tanzi M, Benedetti E, Pollak R. Medication noncompliance after kidney transplantation. Am J Health-Syst Pharm 2003; 60: 266.
18. Ghods AJ, Nasrollahzadeh D. Noncompliance with immunosuppressive medications after renal transplant. Exp Clin Transplant 2003; 1: 39.
19. Rosenberger J, Geckova AM, van Dijk JP, et al. Prevalence and characteristics of noncompliant behaviour and its risk factors in kidney transplant recipients. Transpl Int 2005; 18: 1072.
20. Chisholm MA, Lance CE, Mulloy LL. Patient factors associated with immunosuppressant therapy adherence in renal transplant recipients. Am J Health-Syst Pharm 2005; 62: 1775.
21. Chisholm MA, Williamson GM, Lance CE, Mulloy LL. Predicting adherence to immunosuppressant therapy: a prospective analysis of the Theory of Planned Behavior. Nephrol Dial Transplant 2007. Available at http://ndt. oxfordjournals.org/cgi/reprint/gfm149?ijkey=3Ez87tu0XsYaNOL&keytype=ref.
22. United Network for Organ Sharing [UNOS]. (2007). Types of data collected. Available at http://www.unos.org/data/about/collection.asp. Accessed April 3, 2007.
23. Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation 2000; 70: 1240.
24. Ng N, Van Minh H, Tesfaye F, et al. Combining risk factors and demographic surveillance: potentials of WHO STEPS and INDEPTH methodologies for assessing epidemiological transition. Scand J Public Health 2006; 34: 199.
25. Hahn RA, Stroup DF. Race and ethnicity in public health surveillance: Criteria for the scientific use of social categories. Public Health Rep 1994; 109: 7.
26. Meigs J.B. Epidemiology of the insulin resistance syndrome. Curr Diab Rep 2003; 3: 73.
27. Berkwits M, Guallar E. Risk factors, risk prediction, and the apolipoprotein B-apolipoprotein A-I ratio. Ann Intern Med 2007; 146: 677.
28. Yen EF, Hardinger K, Brennan DC, et al. Cost-effectiveness of extending Medicare coverage of immunosuppressive medications to the life of a kidney transplant. Am J Transplant 2004; 4: 1703.
29. Chisholm MA, Roberts E. Medicare Part D coverage and its influence on transplant patients' out of pocket prescription expenses. Am J Transplant 2006; 6: 1737.
30. Hauboldt, R.H. 2006 US organ and tissue transplant cost estimates. Milliman; 2006. Available at: http://www.milliman.com/pubs/Healthcare/content/ research_reports/US-Organ-Tissue-Transplant-2006-RR.pdf. Accessed March 7, 2007.
31. Rovelli M, Palmeri D, Vossler E, et al. Noncompliance in renal transplant recipients: Evaluation by socioeconomic groups. Transplant Proc 198; 21: 3 979.
32. Rovelli M, Palmeri D, Vossler E, et al. Noncompliance in organ transplant recipients. Transplant Proc 1989; 21: 833.
33. Woodward RS, Schnitzler MA, Lowell J, et al. Effect of extended coverage of immunosuppressive medications by Medicare on the survival of cadaveric renal transplants. Am J Transplant 2001; 1: 69.
34. Red Book 2006 Edition. Montvale, NJ: Thomson; 2006.
35. Dickenmann MJ, Nickeleit V, Tsinalis D, et al. Why do kidney grafts fail? A long-term single-center experience. Transpl Int 2002; 15: 508.
36. Cleemput I, Kesteloot K, Vanrenterghem Y, De Geest S. The economic implications of nonadherence after renal transplantation. Pharmacoeconomics 2004; 18: 1217.
37. Butler JA, Peveler RC, Roderick P, et al. Measuring compliance with drug regimens after renal transplantation: Comparison of self-report and clinician rating with electronic monitoring. Transplantation 2004; 77: 786.
38. Byerly M, Fisher R, Whatley K, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 2005; 133: 129.
39. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation. Transplantation 2007; 83: 858.
40. Blowley DL, Hébert D, Arbus GS, et al. Compliance with cyclosporine in adolescent renal transplant recipients. Pediatr Nephrol 1997; 11: 547.
41. Bunchman TE. Compliance in pediatric transplant. Pediatr Transplant 2000; 4: 165.
42. Watson AR. Noncompliance and transfer from paediatric to adult transplant unit. Pediatr Nephrol 2000; 14: 469.